SGTX Sigilon Therapeutics, Inc.

Sigilon is a clinical-stage biotechnology company pioneering a new class of therapeutics and seeking to develop functional cures for patients with chronic diseases.

$3.10  -0.04 (-1.27%)
As of 12/02/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/03/2020
Outstanding shares:  32,309,309
Average volume:  122,722
Market cap:   $101,451,230
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    82657L107
ISIN:        US82657L1070
Sedol:      BLGZBP7
Valuation   (See tab for details)
PE ratio:   -1.34
PB ratio:   1.07
PS ratio:   8.93
Return on equity:   -80.12%
Net income %:   -657.77%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy